SEARCH

SEARCH BY CITATION

References

  • 1
    Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003; 63: 181723.
  • 2
    Yasui T, Iguchi M, Suzuki S, Kohri K. Prevalence and epidemiological characteristics of uroliothiasis in Japan: national trends between 1965 and 2005. Urology. 2008; 71: 20913.
  • 3
    Khan SR, Glenton PA, Backov R, Talham DR. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int. 2002; 62: 206272.
  • 4
    Asselman M, Verhulst A, De Broe ME, Verkoelen CF. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol. 2003; 14: 315566.
  • 5
    Hirose M, Tozawa K, Okada A, Hamamoto S, Shimizu H, Kubota Y, Itoh Y, Yasui T, Kohri K. Glyoxylate induces renal tubular cell injury and microstructural changes in experimental mouse. Urol Res. 2008; 36: 13947.
  • 6
    Byer K, Khan SR. Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol. 2005; 173: 6406.
  • 7
    Moriyama MT, Suga K, Miyazawa K, Tanaka T, Higashioka M, Noda K, Oka M, Tanaka M, Suzuki K. Inhibitions of urinary oxidative stress and renal calcium level by an extract of Quercus salicina Blume/Quercus stenophylla Makino in a rat calcium oxalate urolithiasis model. Int J Urol. 2009; 16: 397401.
  • 8
    Boyce WH. Organic matrix of human urinary concretions. Am J Med. 1968; 45: 67383.
  • 9
    Ryall RL, Fleming DE, Grover PK, Chauvet M, Dean CJ, Marshall VR. The hole truth: intracrystalline proteins and calcium oxalate kidney stones. Mol Urol. 2000; 4: 391402.
  • 10
    Fleming DE, van Riessen A, Chauvet MC, Grover PK, Hunter B, van Bronswijk W, Ryall RL. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate. J Bone Miner Res. 2003; 18: 128291.
  • 11
    Konya E, Umekawa T, Iguchi M, Kurita T. The role of osteopontin on calcium oxalate crystal formation. Eur Urol. 2003; 43: 56471.
  • 12
    Kohri K, Suzuki Y, Yoshida K, Yamamoto K, Amasaki N, Yamate T, Umekawa T, Iguchi M, Sinohara H, Kurita T. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun. 1992; 184: 85964.
  • 13
    Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Sinohara H, Kurita T. Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem. 1993; 268: 151804.
  • 14
    Okada A, Nomura S, Saeki Y, Higashibata Y, Hamamoto S, Hirose M, Itoh Y, Yasui T, Tozawa K, Kohri K. Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res. 2008; 23: 162937.
  • 15
    Hamamoto S, Nomura S, Yasui T, Okada A, Hirose M, Shimizu H, Itoh Y, Tozawa K, Kohri K. Effects of impaired functional domains of osteopontin on renal crystal formation: Analyses of OPN-transgenic and OPN-knockout mice. J Bone Miner Res. 2010; 25: 243647.
  • 16
    Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J. 1993; 7: 147582.
  • 17
    Pepinsky RB, Mumford RA, Chen LL, Leone D, Amo SE, Riper GV, Whitty A, Dolinski B, Lobb RR, Dean DC, Chang LL, Raab CE, Si Q, Hagmann WK, Lingham RB. Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1. Biochemistry. 2002; 41: 712541.
  • 18
    Senger DR, Perruzzi CA, Gracey CF, Papadopoulos A, Tenen DG. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res. 1998; 48: 57704.
  • 19
    Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell. 1994; 5: 56574.
  • 20
    Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000; 287: 8604.
  • 21
    Nishimichi N, Higashikawa F, Kinoh HH, Tateishi Y, Matsuda H, Yokosaki Y. Polymeric osteopontin employs integrin α9β1 as a receptor and attracts neutrophils by presenting a de novo binding site. J Biol Chem. 2009; 284: 1476976.
  • 22
    Yamamoto N, Sakai F, Kon S, Morimoto J, Kimura C, Yamazaki H, Okazaki I, Seki N, Fujii T, Uede T. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest. 2003; 112: 1818.
  • 23
    He CJ, Rondeau E, Medcalf RL, Lacave R, Schleuning WD, Sraer JD. Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol. 1991; 146: 13140.
  • 24
    Rondeau E, He CJ, Zacharias U, Sraer JD. Thrombin stimulation of renal cells. Semin Thromb Hemost. 1996; 22: 1358.
  • 25
    Grandaliano G, Monno R, Ranieru E, Gesualdo L, Schena FP, Martino C, Ursi M. Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol. 2000; 11: 101625.
  • 26
    Vesey DA, Cheung CW, Kruger WA, Poronnik P, Gobe G, Johnson DW. Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. Kidney Int. 2005; 67: 131529.
  • 27
    Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res. 2005; 33: 34957.
  • 28
    Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress. Urol Res. 2005; 33: 2616.
  • 29
    Hirose M, Yasui T, Okada A, Hamamoto S, Shimizu H, Itoh Y, Tozawa K, Kohri K. Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol. 2010; 17: 8392.
  • 30
    Seier AM, Renkl AC, Schulz G, Uebele T, Sindrilaru A, Iben S, Liaw L, Kon S, Uede T, Weiss JM. Antigen-specific induction of osteopontin contributes to the chronification of allergic contact dermatitis. Am J Pathol. 2010; 176: 24658.
  • 31
    Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest. 1995; 101: 146878.
  • 32
    Okada A, Nomura S, Higashibata Y, Hirose M, Gao B, Yoshimura M, Itoh Y, Yasui T, Tozawa K, Kohri K. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res. 2007; 35: 8999.
  • 33
    Yamamoto N, Nakashima T, Torikai M, Naruse T, Morimoto J, Kon S, Sakai F, Uede T. Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol. 2007; 7: 146070.
  • 34
    Pizzolato P. Histochemical recognition of calcium oxalate. J Histochem Cytochem. 1964; 12: 3336.
  • 35
    Gibson UFM, Heid CA, Williams PMA. Novel method for real-time quantitative RT-PCR. Genome Res. 1996; 6: 9951001.
  • 36
    Chauvet MC, Ryall RL. Intracrystalline proteins and calcium oxalate degradation in MDCK II cells. J Struct Biol. 2005; 151: 127.
  • 37
    Lieske JC, Leonard R, Toback FG. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells inhibited by specific anions. Am J Physiol. 1995; 268: 60412.
  • 38
    Ohshima S, Yamaguchi N, Nishioka K, Mima T, Ishii T, Umeshita-Sasai M, Kobayashi H, Shimizu M, Katada Y, Wakitani S, Murata N, Nomura S, Matsuno H, Katayama R, Kon S, Inobe M, Uede T, Kawase I, Saeki Y. Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol. 2002; 29: 20617.
  • 39
    Diao H, Kon S, Iwabuchi K, Kimura C, Morimoto J, Ito D, Segawa T, Maeda M, Hamuro J, Nakayama T, Taniguchi M, Yagita H, Van Kaer L, Onóe K, Denhardt D, Rittling S, Uede T. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity. 2004; 21: 53950.
  • 40
    Zheng W, Li R, Pan H, He D, Xu R, Guo TB, Guo Y, Zhang JZ. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis Rheum. 2009; 60: 195765.
  • 41
    Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol. 2005; 173: 2715.
  • 42
    Tozawa K, Yasui T, Okada A, Hirose M, Hamamoto S, Itoh Y, Kohri K. NF-kappaB activation in renal tubular epithelial cells by oxalate stimulation. Int J Urol. 2008; 15: 9248.
  • 43
    Lieske JC, Deganello S, Toback FG. Cell-crystal interactions and kidney stone formation. Nephron. 1999; 81: 817.
  • 44
    Kok DJ, Khan SR. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int. 1994; 46: 84754.
  • 45
    Yasui T, Fujita K, Asai K, Kohri K. Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells. Int J Urol. 2002; 9: 1008.